Flowers Foods: When a 13.7% Yield Is Already Cut in Half

Flowers Foods: When a 13.7% Yield Is Already Cut in Half

Do you know what scares me more than a high dividend yield? A high dividend yield that no longer exists. Screen Flowers Foods (NYSE: FLO) and this is what you get: a trailing dividend yield above 12%, a forward yield near 13.7%, and a consumer-staples name sitting 34% below where it started the year. For anyone building retirement income, that combination usually means one of two things: a gift, or a trap. The second-quarter report, released after the close on August 20, settles which one this is — and it does so before the price data even gets a word in.

The dividend was already cut. The screen just hasn't caught up.

In February, Flowers raised its quarterly dividend to $0.2475 a share — an increase of 3.1%, its 94th consecutive quarterly payout. Three months later, on May 21 alongside the first-quarter report, the board reset the payout to $0.1250 a share, or $0.50 a year. That is a cut of essentially half — the first break in a dividend record spanning 23 consecutive years, with increases in each of the past 11, according to the data service I use. The first reduced check, payable June 26, is now part of the record.

The reason the screen still flashes a 13.7% forward yield is that the figure simply annualizes the old $0.2475 rate against today's price. Run the math on the dividend that actually exists — $0.50 a share against a stock trading around $7.20 — and the real forward yield on the new payout is closer to 7%. The "13.7% consumer-staples yield" never existed as something you could collect. This is the first law of dividend red flags: when a yield looks too good to be true, check whether the dividend being annualized is still payable.

Why the board acted: a pricing-power test failing in real time

The second-quarter release — 12 weeks ended July 18 — is the clearest window into what forced management's hand. Net sales fell 4.0% to $1.193 billion. The split matters more than the total. Flowers pushed overall pricing and mix up 1.8% and watched volume fall 5.8%. In branded retail — Nature's Own, Wonder, Dave's Killer Bread — the company took 3.8% more price and got back 7.6% lower volume, the steepest branded decline in recent quarters. Adjusted EBITDA — earnings before interest, taxes, depreciation and amortization, a rough cash-earnings proxy — dropped 19.2% to $111.3 million, and adjusted diluted earnings fell to $0.21 a share from $0.30.

Read those numbers as one fact, not two: when a price increase costs you more volume than it gains you, that is not pricing power — it is a price increase. Real pricing power is the ability to raise prices without losing customers. Flowers raised prices; customers answered at the shelf by trading down. If you own income stocks, that distinction is the entire ballgame.

The macro shadow: what the inflation era left behind

The trade-down is not a quarterly accident; it is the residue of three years of elevated prices. Store-brand dollar share of fresh packaged bread has climbed from 23.0% in 2021 to 26.2% in the 52 weeks ended July 19, 2026, while branded bread fell from 77.0% to 73.8%. This is the neglected flip side of a sticky-inflation world: higher shelf prices did not destroy demand for bread, they retrained shopper behavior. Households that learned to reach for the store brand during the 2021–2024 inflation spell do not un-learn it now that wheat costs moderate. Ingredient costs are coming down, which helps a bakery that can hold volume and does nothing for one that cannot.

Management's response — relaunching Nature's Own, sharpening the value proposition, and a cost program worth roughly $20 million annualized (about 4% of EBITDA) — is genuine self-help, but it is self-help against a trend that has been running for years. Flowers' share of the total bread category fell to 15.5% in the second quarter from 16.8% in late 2024. Budget pressure, trade-down activity and competition are the words management used for the demand backdrop — and none of those three is a next-quarter problem.

Is the new, halved dividend even safe?

The reset — a halved payout on top of freshly trimmed 2026 guidance — at least asks the right question: does the new dividend stand on its own? By the arithmetic, yes, more or less. The $0.50 payout is roughly 60% of the midpoint of the lowered 2026 adjusted EPS guidance of $0.75–0.85, which itself sits well below the $1.09 the company earned in fiscal 2025 and below the $0.80–0.90 it was still forecasting this spring. Trailing free cash flow of about $306 million covers the roughly $107 million annualized payout nearly three times over.

That is exactly what a reset is supposed to achieve, and it explains the previous dividend's fate. At the old $0.99 annual rate, the payout consumed roughly 124% of even the midpoint of the new guidance — the trailing payout ratio prints above 280% only because it stacks the old dividend against a depressed earnings base. The board cut because paying the old rate was no longer affordable; the new rate is.

But a reset buys time; it does not buy a moat. The balance sheet that forced the cut is still stretched: net debt of roughly $1.6 billion stands against a market capitalization near $1.5 billion, debt to equity runs around 127%, short-term obligations exceed short-term assets (a current ratio below 1), free cash flow is shrinking about 24% year over year, and a debt maturity in October looms. Credit the company for repaying roughly $70 million of debt this year and holding $52.8 million in cash. Still, having to break a two-decade payout record to make that progress is the most honest statement management has made all year about the near-term profit outlook.

This is not the "buy quality on a dip" setup

My usual instinct when a good franchise sinks out of favor is to lean in — that is the equity yield curve in practice, buying durable cash flows when a downturn inflates their yields. I don't think that logic applies here, and the reason is specific. That framework requires intact pricing power and a payout that survives a cycle. Flowers has neither bankable right now: a thinning moat against private label and a balance sheet that already forced a near-50% dividend cut.

The relative yields confirm where the market has landed. A large, healthy staple screens near 6% today; a genuinely distressed pantry name screens near 19% with negative earnings. Flowers' true forward rate on its halved payout is around 7%. The market has already repriced the reset — what remains is a leveraged franchise losing shelf share every quarter, paying out roughly 60% of freshly lowered earnings. That is not income growth; it is what remains of a yield that was 13.7% on paper and 13.7% nowhere else.

I don't think this is an income position. At best it is a small, actively monitored turnaround that requires three things to go right — branded volume stabilizing, private-label share pressure plateauing, and a clean path through the October maturity. Nothing in the August release shows any of the three arriving. Called out for what it is, the "high yield" was not an opportunity; it was the lag between when the dividend died and when the screen found out.

The lesson travels. The first question about any income idea is never "what's the yield?" It is "can this company raise prices without losing customers?" That filter flagged Flowers before the cut was ever announced: a price increase that buys demand destruction is not a moat, and a dividend is only as safe as the moat underneath it. I would rather own a 2% yield compounding at double-digit growth than a 13.7% figure that stopped existing the day the board met.